6XT.F ASAHI INTECC CO. LTD.
- Market cap
- EUR 5.62B
- P/E
- 31.6x
- P/B
- 5.81x
- ROE
- 18.5%
- Dividend yield
- 1.33%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 6XT.F undervalued?
Graham number6XT.F trades 185.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ASAHI INTECC CO. LTD. fundamental analysis
No fundamental analysis for ASAHI INTECC CO. LTD. yet.
ASAHI INTECC CO. LTD. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ASAHI INTECC CO. LTD.
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. The company operates through the Medical and Device segments. It provides guide wires, guiding catheters, balloon catheters, penetration catheters, microcatheter for endovascular treatment; gastrointestinal endoscopy device such as guidewire and dilator; and robotic system and software. The company also offers OEM ODM se…
Full company profileASAHI INTECC CO. LTD. financial statements
ASAHI INTECC CO. LTD. annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 77.7B | 90.1B | 108B | 120B | 145B |
| Gross Profit | 51.1B | 58.8B | 69.1B | 81.2B | 102B |
| Operating Income | 15.2B | 18.0B | 22.1B | 30.1B | 45.2B |
| EBITDA | - | 26.8B | 31.7B | 29.0B | 53.7B |
| Net Income | 10.9B | 13.1B | 15.8B | 12.7B | 32.1B |
| EPS | 40 | 48 | 58 | 47 | 121 |
| Balance Sheet | |||||
| Total Assets | 155B | 173B | 192B | 193B | 218B |
| Total Liabilities | 34.0B | 38.3B | 39.7B | 41.8B | 43.9B |
| Shareholders' Equity | 119B | 132B | 151B | 151B | 173B |
| Cash & Short-term Investments | 32.3B | 34.9B | 35.7B | 54.2B | 64.3B |
| Cash Flow | |||||
| Operating Cash Flow | 17.3B | 19.1B | 34.7B | 40.5B | 40.1B |
| Capital Expenditure | 8.56B | 12.7B | 10.5B | 8.58B | 8.93B |
| Free Cash Flow | 8.74B | 6.43B | 24.2B | 32.0B | 31.2B |
| Ratios | |||||
| ROE | 9.1% | 9.9% | 10.5% | 8.5% | 18.5% |
| ROA | 7.0% | 7.6% | 8.2% | 6.6% | 14.7% |
| Net Profit Margin | 14.0% | 14.5% | 14.7% | 10.6% | 22.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ASAHI INTECC CO. LTD. dividends
- Dividend yield
- 1.33%
- Forward dividend
- 0.28 EUR
- Payout ratio
- 20.4%
- Ex-dividend date
- Jun 29, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 6.53B | 25 | 20.4% |
| 2025 | JPY 5.53B | 21 | 43.4% |
| 2024 | JPY 3.93B | 14 | 24.9% |
| 2023 | JPY 3.26B | 12 | 24.8% |
| 2022 | JPY 2.99B | 11 | 27.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ASAHI INTECC CO. LTD.
- Insiders 16.97%
- Institutions 44.45%
- Public & others 38.59%
- Shares outstanding 265M
- Free float 218M
ASAHI INTECC CO. LTD. company profile
- Company name
- ASAHI INTECC CO. LTD.
- Ticker
- 6XT.F
- ISIN
- JP3110650003
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 10,177
- Fiscal year end
- June
- Address
- 3-100 Akatsuki-cho, Seto, Japan, 489-0071
- Phone
- 81 5 6148 5551
- Website
- asahi-intecc.co.jp
About ASAHI INTECC CO. LTD.
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. The company operates through the Medical and Device segments. It provides guide wires, guiding catheters, balloon catheters, penetration catheters, microcatheter for endovascular treatment; gastrointestinal endoscopy device such as guidewire and dilator; and robotic system and software. The company also offers OEM ODM service services for medical devices; and medical and industrial components, such as wire rope, coils, coatings, tubes, terminal processing products synchromesh wire rope, cable rack, torque rope, mechanical polishing, flexible shaft, and option parts. In addition, it develops, manufactures, and sells ultra-fine stainless steel wire ropes. It serves office automation equipment, housing, and automobiles industries. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was founded in 1972 and is headquartered in Seto, Japan.
ASAHI INTECC CO. LTD. management
10- Mr. Kenji MiyataPresident, CEO & Director · born 1970
- Ms. Mizuho ItoGM of Corporate Strategic Office, Administration Division, CFO & Director · born 1973
- Mr. Shinjiro OtaniGM of Human Resources Development Division & Director · born 1975
- Mr. Ippei YugawaHead of Affiliates & Executive Officer · born 1956
- Mr. Tadakazu KatoSenior Executive Officer · born 1954
- Mr. Yoshinori TeraiGM of New Business Development Division & Director · born 1963
- Yuichi IizukaSenior Executive Officer
- Mr. Munechika MatsumotoSenior Executive Officer · born 1954
- Mr. Makoto NishiuchiGM of Medical Brand Business Unit of Medical Division, Chief Digital Officer & Executive Director · born 1964
- Mr. Kazuhito IshiharaSupervisor of R&D of Medical Brand Biz. of Medical Div., DGM of Medical Business Div. and Director · born 1961